Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_provenance.
- NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_assertion description "[Inhibiting antiapoptotic BCL-2 and its relatives is an attractive strategy for sensitizing lymphoid malignancies to drugs but it has been largely unsuccessful for melanoma and other solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_provenance.
- NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_assertion evidence source_evidence_literature NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_provenance.
- NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_assertion SIO_000772 22173547 NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_provenance.
- NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_assertion wasDerivedFrom befree-20140225 NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_provenance.
- NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_assertion wasGeneratedBy ECO_0000203 NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP262829.RADPm_osUQPaOB_3f4F4-J5HHGGz4BDcVrT6TnKtLFRPo130_provenance.